190 related articles for article (PubMed ID: 34400804)
1. Risk of COVID-19 death in cancer patients: an analysis from Guy's Cancer Centre and King's College Hospital in London.
Russell B; Moss CL; Shah V; Ko TK; Palmer K; Sylva R; George G; Monroy-Iglesias MJ; Patten P; Ceesay MM; Benjamin R; Potter V; Pagliuca A; Papa S; Irshad S; Ross P; Spicer J; Kordasti S; Crawley D; Wylie H; Cahill F; Haire A; Zaki K; Sita-Lumsden A; Josephs D; Enting D; Swampillai A; Sawyer E; D'Souza A; Gomberg S; Harrison C; Fields P; Wrench D; Rigg A; Sullivan R; Kulasekararaj A; ; Dolly S; Van Hemelrijck M
Br J Cancer; 2021 Sep; 125(7):939-947. PubMed ID: 34400804
[TBL] [Abstract][Full Text] [Related]
2. Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective observational study.
Monin L; Laing AG; Muñoz-Ruiz M; McKenzie DR; Del Molino Del Barrio I; Alaguthurai T; Domingo-Vila C; Hayday TS; Graham C; Seow J; Abdul-Jawad S; Kamdar S; Harvey-Jones E; Graham R; Cooper J; Khan M; Vidler J; Kakkassery H; Sinha S; Davis R; Dupont L; Francos Quijorna I; O'Brien-Gore C; Lee PL; Eum J; Conde Poole M; Joseph M; Davies D; Wu Y; Swampillai A; North BV; Montes A; Harries M; Rigg A; Spicer J; Malim MH; Fields P; Patten P; Di Rosa F; Papa S; Tree T; Doores KJ; Hayday AC; Irshad S
Lancet Oncol; 2021 Jun; 22(6):765-778. PubMed ID: 33930323
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics and risk factors associated with COVID-19 severity in patients with haematological malignancies in Italy: a retrospective, multicentre, cohort study.
Passamonti F; Cattaneo C; Arcaini L; Bruna R; Cavo M; Merli F; Angelucci E; Krampera M; Cairoli R; Della Porta MG; Fracchiolla N; Ladetto M; Gambacorti Passerini C; Salvini M; Marchetti M; Lemoli R; Molteni A; Busca A; Cuneo A; Romano A; Giuliani N; Galimberti S; Corso A; Morotti A; Falini B; Billio A; Gherlinzoni F; Visani G; Tisi MC; Tafuri A; Tosi P; Lanza F; Massaia M; Turrini M; Ferrara F; Gurrieri C; Vallisa D; Martelli M; Derenzini E; Guarini A; Conconi A; Cuccaro A; Cudillo L; Russo D; Ciambelli F; Scattolin AM; Luppi M; Selleri C; Ortu La Barbera E; Ferrandina C; Di Renzo N; Olivieri A; Bocchia M; Gentile M; Marchesi F; Musto P; Federici AB; Candoni A; Venditti A; Fava C; Pinto A; Galieni P; Rigacci L; Armiento D; Pane F; Oberti M; Zappasodi P; Visco C; Franchi M; Grossi PA; Bertù L; Corrao G; Pagano L; Corradini P;
Lancet Haematol; 2020 Oct; 7(10):e737-e745. PubMed ID: 32798473
[TBL] [Abstract][Full Text] [Related]
4. The impact of hospital attendance on COVID-19 infection in cancer patients: an assessment of data from Guy's Cancer.
Tremble K; Fox L; Moss C; Russell B; Aljazzaf H; Higgins F; Dann B; Jogia V; Roberts G; Rigg A; Dolly S; Van Hemelrijck M
Future Oncol; 2022 Mar; 18(10):1211-1218. PubMed ID: 35034514
[TBL] [Abstract][Full Text] [Related]
5. Epidemiology and clinical course of severe acute respiratory syndrome coronavirus 2 infection in cancer patients in the Veneto Oncology Network: The Rete Oncologica Veneta covID19 study.
Guarneri V; Bassan F; Zagonel V; Milella M; Zaninelli M; Cattelan AM; Vianello A; Gori S; Aprile G; Azzarello G; Chiari R; Favaretto A; Oliani C; Scola A; Pastorelli D; Mandarà M; Zustovich F; Bernardi D; Chiarion-Sileni V; Morandi P; Toso S; Di Liso E; Ziampiri S; Caccese M; Zampiva I; Puccetti O; Celestino M; Dieci MV; Conte P;
Eur J Cancer; 2021 Apr; 147():120-127. PubMed ID: 33647547
[TBL] [Abstract][Full Text] [Related]
6. Impact of hematologic malignancy and type of cancer therapy on COVID-19 severity and mortality: lessons from a large population-based registry study.
García-Suárez J; de la Cruz J; Cedillo Á; Llamas P; Duarte R; Jiménez-Yuste V; Hernández-Rivas JÁ; Gil-Manso R; Kwon M; Sánchez-Godoy P; Martínez-Barranco P; Colás-Lahuerta B; Herrera P; Benito-Parra L; Alegre A; Velasco A; Matilla A; Aláez-Usón MC; Martos-Martínez R; Martínez-Chamorro C; Susana-Quiroz K; Del Campo JF; de la Fuente A; Herráez R; Pascual A; Gómez E; Pérez-Oteyza J; Ruiz E; Alonso A; González-Medina J; Martín-Buitrago LN; Canales M; González-Gascón I; Vicente-Ayuso MC; Valenciano S; Roa MG; Monteliu PE; López-Jiménez J; Escobar CE; Ortiz-Martín J; Diez-Martin JL; Martinez-Lopez J;
J Hematol Oncol; 2020 Oct; 13(1):133. PubMed ID: 33032660
[TBL] [Abstract][Full Text] [Related]
7. Clinical profile and outcome of COVID-19 in haematological malignancies: experience from tertiary care centre in India.
Gupta A; Desai N; Sanjeev ; Chauhan P; Nityanand S; Hashim Z; Gupta M
Ann Hematol; 2022 Jan; 101(1):69-79. PubMed ID: 34559278
[TBL] [Abstract][Full Text] [Related]
8. Factors Affecting COVID-19 Outcomes in Cancer Patients: A First Report From Guy's Cancer Center in London.
Russell B; Moss C; Papa S; Irshad S; Ross P; Spicer J; Kordasti S; Crawley D; Wylie H; Cahill F; Haire A; Zaki K; Rahman F; Sita-Lumsden A; Josephs D; Enting D; Lei M; Ghosh S; Harrison C; Swampillai A; Sawyer E; D'Souza A; Gomberg S; Fields P; Wrench D; Raj K; Gleeson M; Bailey K; Dillon R; Streetly M; Rigg A; Sullivan R; Dolly S; Van Hemelrijck M
Front Oncol; 2020; 10():1279. PubMed ID: 32903324
[No Abstract] [Full Text] [Related]
9. Immunogenicity of the BNT162b2 COVID-19 mRNA vaccine and early clinical outcomes in patients with haematological malignancies in Lithuania: a national prospective cohort study.
Maneikis K; Šablauskas K; Ringelevičiūtė U; Vaitekėnaitė V; Čekauskienė R; Kryžauskaitė L; Naumovas D; Banys V; Pečeliūnas V; Beinortas T; Griškevičius L
Lancet Haematol; 2021 Aug; 8(8):e583-e592. PubMed ID: 34224668
[TBL] [Abstract][Full Text] [Related]
10. A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.
Moreno-González G; Mussetti A; Albasanz-Puig A; Salvador I; Sureda A; Gudiol C; Salazar R; Marin M; Garcia M; Navarro V; de la Haba Vaca I; Coma E; Sanz-Linares G; Dura X; Fontanals S; Serrano G; Cruz C; Mañez R
Trials; 2021 Feb; 22(1):116. PubMed ID: 33546739
[TBL] [Abstract][Full Text] [Related]
11. Outcomes of patients with hematologic malignancies and COVID-19 from the Hematologic Cancer Registry of India.
Jain A; Nayak L; Kulkarni UP; Mehra N; Yanamandra U; Kayal S; Damodar S; John JM; Mehta P; Singh S; Munot P; Selvarajan S; Radhakrishnan V; Lad D; Kapoor R; Dubashi B; Bharath RS; Jain H; Jayachandran PK; Lakshmanan J; Mani T; Thorat J; Das S; Karunamurthy O; George B; Sengar M; Malhotra P
Blood Cancer J; 2022 Jan; 12(1):2. PubMed ID: 34987161
[No Abstract] [Full Text] [Related]
12. Poor outcome and prolonged persistence of SARS-CoV-2 RNA in COVID-19 patients with haematological malignancies; King's College Hospital experience.
Shah V; Ko Ko T; Zuckerman M; Vidler J; Sharif S; Mehra V; Gandhi S; Kuhnl A; Yallop D; Avenoso D; Rice C; Sanderson R; Sarma A; Marsh J; de Lavallade H; Krishnamurthy P; Patten P; Benjamin R; Potter V; Ceesay MM; Mufti GJ; Norton S; Pagliuca A; Galloway J; Kulasekararaj AG
Br J Haematol; 2020 Sep; 190(5):e279-e282. PubMed ID: 32526039
[No Abstract] [Full Text] [Related]
13. Clinical course and risk factors for mortality from COVID-19 in patients with haematological malignancies.
Sanchez-Pina JM; Rodríguez Rodriguez M; Castro Quismondo N; Gil Manso R; Colmenares R; Gil Alos D; Paciello ML; Zafra D; Garcia-Sanchez C; Villegas C; Cuellar C; Carreño-Tarragona G; Zamanillo I; Poza M; Iñiguez R; Gutierrez X; Alonso R; Rodríguez A; Folgueira MD; Delgado R; Ferrari JM; Lizasoain M; Aguado JM; Ayala R; Martinez-Lopez J; Calbacho M
Eur J Haematol; 2020 Nov; 105(5):597-607. PubMed ID: 32710500
[TBL] [Abstract][Full Text] [Related]
14. Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19.
Cattaneo C; Daffini R; Pagani C; Salvetti M; Mancini V; Borlenghi E; D'Adda M; Oberti M; Paini A; De Ciuceis C; Barbullushi K; Cancelli V; Belotti A; Re A; Motta M; Peli A; Bianchetti N; Anastasia A; Dalceggio D; Roccaro AM; Tucci A; Cairoli R; Muiesan ML; Rossi G
Cancer; 2020 Dec; 126(23):5069-5076. PubMed ID: 32910456
[TBL] [Abstract][Full Text] [Related]
15. Covid-19 in patients with hematological and solid cancers at a Comprehensive Cancer Center in Germany.
Shoumariyeh K; Biavasco F; Ihorst G; Rieg S; Nieters A; Kern WV; Miething C; Duyster J; Engelhardt M; Bertz H
Cancer Med; 2020 Nov; 9(22):8412-8422. PubMed ID: 32931637
[TBL] [Abstract][Full Text] [Related]
16. Clinical characteristics, outcomes, and risk factors for mortality in patients with cancer and COVID-19 in Hubei, China: a multicentre, retrospective, cohort study.
Yang K; Sheng Y; Huang C; Jin Y; Xiong N; Jiang K; Lu H; Liu J; Yang J; Dong Y; Pan D; Shu C; Li J; Wei J; Huang Y; Peng L; Wu M; Zhang R; Wu B; Li Y; Cai L; Li G; Zhang T; Wu G
Lancet Oncol; 2020 Jul; 21(7):904-913. PubMed ID: 32479787
[TBL] [Abstract][Full Text] [Related]
17. Reduction in the rate and improvement in the prognosis of COVID-19 in haematological patients over time.
Cattaneo C; Pagani C; Cancelli V; Imberti L; Roccaro AM; Notarangelo LD; Rossi G
Leukemia; 2021 Feb; 35(2):632-634. PubMed ID: 32770087
[No Abstract] [Full Text] [Related]
18. Illness duration and symptom profile in symptomatic UK school-aged children tested for SARS-CoV-2.
Molteni E; Sudre CH; Canas LS; Bhopal SS; Hughes RC; Antonelli M; Murray B; Kläser K; Kerfoot E; Chen L; Deng J; Hu C; Selvachandran S; Read K; Capdevila Pujol J; Hammers A; Spector TD; Ourselin S; Steves CJ; Modat M; Absoud M; Duncan EL
Lancet Child Adolesc Health; 2021 Oct; 5(10):708-718. PubMed ID: 34358472
[TBL] [Abstract][Full Text] [Related]
19. One Piece of the Jigsaw for the Cancer Recovery Strategy: Prevalence of COVID-19 in Patients With Cancer.
Moss C; Dolly S; Russell B; Lei M; Ghosh S; Papa S; Sullivan R; Van Hemelrijck M; Rigg A;
Cancer Control; 2020; 27(3):1073274820950844. PubMed ID: 32885663
[TBL] [Abstract][Full Text] [Related]
20. COVID-19 in children with haematological malignancies.
Millen GC; Arnold R; Cazier JB; Curley H; Feltbower R; Gamble A; Glaser A; Grundy RG; Kirton L; Lee LYW; McCabe MG; Palles C; Phillips B; Stiller CA; Varnai C; Kearns P
Arch Dis Child; 2022 Feb; 107(2):186-188. PubMed ID: 34301621
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
